iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market
Holding ITOS?
Track your performance easily

iTeos Therapeutics (ITOS) Financial Statements

171 Followers

iTeos Therapeutics Financial Overview

iTeos Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.999; its P/E ratio is -3.34; iTeos Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-1.17. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 35.00M----
Gross Profit$ 35.00M----
EBIT$ -4.87M$ -37.75M$ -28.19M$ -33.42M$ -33.07M
EBITDA$ -4.56M$ -37.45M$ -27.96M$ -33.20M$ -32.84M
Net Income Common Stockholders$ -8.54M$ -38.22M$ -30.55M$ -33.29M$ -34.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 571.26M$ 449.14M$ 531.92M$ 599.03M$ 599.22M
Total Assets$ 751.84M$ 629.77M$ 667.59M$ 677.64M$ 703.75M
Total Debt$ 5.52M$ 5.82M$ 6.06M$ 5.93M$ 5.45M
Net Debt$ -565.74M$ -443.32M$ -525.86M$ -593.10M$ -593.78M
Total Liabilities$ 44.93M$ 88.57M$ 92.36M$ 79.38M$ 80.22M
Stockholders Equity$ 663.88M$ 541.20M$ 575.23M$ 598.26M$ 623.53M
Cash Flow-
Free Cash Flow$ -34.37M$ -33.34M$ -15.18M$ -34.72M$ -30.25M
Operating Cash Flow$ -33.93M$ -32.40M$ -13.77M$ -33.89M$ -29.55M
Investing Cash Flow$ 16.32M$ -69.60M$ 61.56M$ 22.69M$ 20.10M
Financing Cash Flow$ 122.38M$ 22.00K$ 307.00K$ 10.00K$ 218.00K
Currency in USD

iTeos Therapeutics Earnings and Revenue History

iTeos Therapeutics Debt to Assets

iTeos Therapeutics Cash Flow

iTeos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis